TrialLeukemia2006
Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation.
F Millot et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled ittrialcites it